Effect of oral creatine supplementation on urinary methylamine, formaldehyde, and formate

Medicine and Science in Sports and Exercise

Volumn 37, Issue 10, 2005, Pages 1717-1720

  Poortmans, Jacques R ^a   Kumps, Alain ^a   Duez, Pierre ^a   Fofonka, Aline ^b   Carpentier, Alain ^a   Francaux, Marc ^b  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Albumin; Creatinine; Cytotoxic compounds; Kidney; Urine

Indexed keywords

CREATINE; CREATININE; FORMALDEHYDE; FORMIC ACID; METHYLAMINE;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONSUMER; CREATININE URINE LEVEL; CYTOTOXICITY; GLOMERULUS; HUMAN; HUMAN EXPERIMENT; KIDNEY FUNCTION; MALE; MICROANGIOPATHY; NORMAL HUMAN; PERMEABILITY; URINALYSIS; URINARY EXCRETION; VENOUS BLOOD;

ADMINISTRATION, ORAL; ADULT; CREATINE; CREATININE; DIETARY SUPPLEMENTS; FORMALDEHYDE; FORMIC ACIDS; HUMANS; MALE; METHYLAMINES;

EID: 27644441867     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1249/01.mss.0000176398.64189.e6     Document Type: Article

References (27)

1. AFSSA. Assessment of the risks of creatine on the consumer and of the veracity of the claims relating to sports performance and the increase of muscle mass. Available at http://www.afssa.fr.
2. BERODE, M., T. SETHRE, T. LAUBLI, and H. SAVOLAINEN. Urinary methanol and formic acid as indicators of occupational exposure to methyl formate. Int. Arch. Occup. Environ. Health. 73:410-414, 2000.
3. BOENIGER, M. F. Formate in urine as a biological indicator of formaldehyde exposure: a review. Am. Ind. Hyg. Assoc. J. 48:900-908, 1987.
4. DENG, Y., F. BOOMSMA, and P. H. YU. Deamination of methylamine and aminoacetone increases aldehydes and oxidative stress in rats. Life Sci. 63:2049-2058, 1998.
5. GARPENSTRAND, H., M. BERGQVIST, D. BRATTSTROM, et al. Serum semicarbazide-sensitive amine oxidase (SSAO) activity correlates with VEGF in non-small-cell lung cancer patients. Med. Oncol. 21:241-250, 2004.
6. GRADY, S., and J. OSTERLOH. Improved enzymic assay for serum formate with colorimetric endpoint. J. Anal. Toxicol. 10:1-5, 1986.
7. KAGE, S., K. KUDO, H. IKEDA, and N. IKEDA. Simultaneous determination of formate and acetate in whole blood and urine from humans using gas chromatography-mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 805:113-117, 2004.
8. KINEMUCHI, H., H. SUGIMOTO, T. OBATA, N. SATOH, and S. UEDA. Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues. Neurotoxicology 25:325-335, 2004.
9. KOSHY, K. M., E. GRISWOLD, and E. E. SCHNEEBERGER. Interstitial nephritis in a patient taking creatine. N. Engl. J. Med. 340:814-815, 1999.
10. LOUIS, M., J. LEBACQ, J. R. POORTMANS, et al. Beneficial effects of creatine supplementation in dystrophic patients. Muscle Nerve 27:604-610, 2003.
11. LUNDH, T., and B. AKESSON. Gas chromatographic determination of primary and secondary low-molecular-mass aliphatic amines in urine using derivatization with isobutyl chloroformate. J. Chromatogr. 617:191-196, 1993.
12. MITCHELL, S. C., and A. Q. ZHANG. Methylamine in human urine. Clin. Chim. Acta 312:107-114, 2001.
13. POORTMANS, J. R., H. AUQUIER, V. RENAUT, A. DURUSSEL, M. SAUGY, and G. R. BRISSON. Effect of short-term creatine supplementation on renal responses in men. Eur. J. Appl. Physiol. Occup. Physiol. 76:566-567, 1997.
14. POORTMANS, J. R., and M. FRANCAUX. Long-term oral creatine supplementation does not impair renal function in healthy athletes. Med. Sci. Sports Exerc. 31:1108-1110, 1999.
15. POORTMANS, J. R., and M. FRANCAUX. Renal dysfunction accompanying oral creatine supplements. Lancet 352:234, 1998.
16. POORTMANS, J. R., and M. FRANCAUX. Renal implications of exogenous creatine monohydrate supplementation. Am. J. Sports Med. 4:212-216, 2002.
17. PRITCHARD, N. R., and P. A. KALRA. Renal dysfunction accompanying oral creatine supplements. Lancet 351:1252-1253, 1998.
18. REMUZZI, G., and J. J. WEENING. Albuminuria as early test for vascular disease. Lancet 365:556-557, 2005.
19. SCHMIDT, F. H. [Faulty measurement of urinary glucose concentration by polarization]. Dtsch. Med. Wochenschr. 92:2025-2027, 1967.
20. SLIKKER, W. J., M. E. ANDERSEN, M. S. BOGDANFFY, et al. Dose-dependent transitions in mechanisms of toxicity: case studies. Toxicol. Appl. Pharmacol. 201:226-294, 2004.
21. SOFFRITTI, M., F. BELPOGGI, L. LAMBERTIN, M. LAURIOLA, M. PADOVANI, and C. MALTONI. Results of long-term experimental studies on the carcinogenicity of formaldehyde and acetaldehyde in rats. Ann. N. Y. Acad. Sci. 982:87-105, 2002.
22. TERJUNG, R. L., P. CLARKSON, E. R. EICHNER, et al. American College of Sports Medicine roundtable. The physiological and health effects of oral creatine supplementation. Med. Sci. Sports Exerc. 32:706-717, 2000.
23. WYSS, M., and R. KADDURAH-DAOUK. Creatine and creatinine metabolism. Physiol. Rev. 80:1107-1213, 2000.
24. YU, P. H., and Y. DENG. Potential cytotoxic effect of chronic administration of creatine, a nutrition supplement to augment athletic performance. Med. Hypotheses. 54:726-728, 2000.
25. YU, P. H., S. WRIGHT, E. H. FAN, Z. R. LUN, and D. GUBISNE-HARBERLE. Physiological and pathological implications of semicarbazide-sensitive amine oxidase. Biochim. Biophys. Acta 1647:193-199, 2003.
26. YU, P. H., and D. M. ZUO. Formaldehyde produced endogenously via deamination of methylamine. A potential risk factor for initiation of endothelial injury. Atherosclerosis 120:189-197, 1996.
27. YU, P. H., and D. M. ZUO. Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes. Diabetes 42:594-603, 1993.